Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
 

Investors

+

Main navigation

Main navigation

  • News - Press releases
  • Financial Calendar
  • Financial reports
    • IPO and listning documents
  • Corporate governance
    • Articles Of Association
    • AGM and Extraordinary general meetings
      • Annual General Meeting on May 5 2022
      • Annual general meeting on 5 May 2021
      • Extraordinary Shareholders Meeting 19 November
      • Extraordinary general meeting January 2020
      • Annual General Meeting, May 20, 2020
    • Auditor
    • Nomination Committee
    • Certified adviser
  • Share information
    • Major shareholders
    • Sharecapital
    • Incentive programme
    • Dividend Policy
    • Warrants (TO)
  • Board
  • Management
  • Insiders
  • IR Contact
  • Presentations
not regulatory
2022-06-30 11:30
Qlife to present poster at PKU conference in the US
The National PKU Alliance (NPKUA) is the largest event for the PKU community in the world and brings together patients, relatives, industry, and research partners every two years. This year, Qlife…
regulatory
2022-06-28 15:36
QLIFE RAISES LOANS OF UP TO SEK 20 MILLION TO COMPLETE CRP AND PHE PRODUCT DEVELOPMENT AND REGISTRATION
The loans are granted by Modelio Equity AB and a large private shareholder in Qlife. The loan term runs over six months from June to December 2022. The loans are entered into on market terms of 1.5%…
not regulatory
2022-06-27 15:44
Qlife receives milestone payment of 1.23 M USD from FIND
In December 2021, Qlife signed an agreement with FIND for $ 3.45 million for a 12-month project with the goal of developing a new and cost-effective two-in-one test for influenza and SARS-CoV-2 virus…
not regulatory
2022-06-20 09:02
Qlife forms Scientific Advisory Board to strengthen its research and development strategy - Dr. Jan Gorm Lisby first to join
By meeting regularly Qlife’s new Scientific Advisory Board will offer insights into the latest development within the specific fields of Molecular Diagnostics. The engagement of the members of the…
regulatory
2022-05-12 09:00
Qlife’s new filtration unit significantly broadens the market for the Egoo platform
Qlife’s scientific team has completed the development of a blood-to-plasma filtration unit for blood-based biomarker testing. The Egoo capsule already integrates all reagents and with the new…
regulatory
2022-05-05 13:10
Bulletin from the annual general meeting in Qlife Holding AB 5 May 2022
Resolution on adoption of accounts and distribution of the company’s result The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income…
regulatory
2022-05-05 09:30
QLIFE HOLDING AB, QUARTERLY REPORT Q1 2022
FINANCIAL SUMMARY – FIRST QUARTER 2022 Revenue in the period amounted to kSEK 10,905 (11,176). Revenue includes sales of Egoo.Health devices and capsules for the device. We saw strong sales…
regulatory
2022-04-06 13:00
QLIFE PUBLISHES ANNUAL REPORT 2021
Qlife Holding AB’s Annual report 2021 is from today available in swedish and english on the company’s website, www.qlifeholding.com. https://qlifeholding.com/sv/investerare/finansiella-…
regulatory
2022-04-04 08:00
Notice of annual general meeting in Qlife Holding AB
Right to participate and notification Shareholders wishing to participate in the annual general meeting must: partly be listed in the company’s share register kept by Euroclear Sweden AB as of…
not regulatory
2022-03-28 10:42
Qlife study follow up - deviations in test execution explain incorrect results
The study set-up was using Hvidovre Hospital best practice for covid-19 testing (RT-qPCR) as the comparator method. Thus, the test execution deviates from the Egoo.Health Intended Use and Instruction…
not regulatory
2022-02-17 10:12
Qlife to follow up Danish clinical evaluation on rapid tests for covid-19
"We are surprised that the results from the Danish clinical evaluation differ from previously scientific and published study on more than 1000 samples, which among others were conducted together…
regulatory
2022-02-17 09:30
QLIFE HOLDING AB, YEAR END REPORT 2021, Q4
FINANCIAL SUMMARY – FOURTH QUARTER 2021 Revenue in the period amounted to kSEK 12,084 (9,122). Revenue regards sales of Egoo.Health devices and COVID-19 test capsules. EBITDA for the period…
regulatory
2021-12-20 16:00
Qlife receives 3,45 MUSD funding from FIND to develop a respiratory assay in global fight against COVID-19 and influenza
Qlife has signed an agreement with FIND, the global alliance for diagnostics, for an funding of 3,45 MUSD for a 12-month project to develop a novel two-in-one assay for the detection of influenza and…
regulatory
2021-11-29 11:34
Qlife recruits Kasper Damgaard Rousøe as new Chief Financial Officer
Kasper Rousøe has more than 20 years of experience from leading roles in the financial area, most recently from Phase One A/S. He has previously been CFO and Finance Director in Bauer Media Group,…
regulatory
2021-11-08 08:30
QLIFE HOLDING AB INTERIM REPORT Q3, 2021
FINANCIAL SUMMARY – THIRD QUARTER 2021 Revenue in the period amounted to kSEK 5,871 (5,062). Sales regards COVID-19 tests from the test service center as well as Egoo.Health devices and capsules…
not regulatory
2021-11-03 16:27
Qlife’s first scientific study of its COVID-19 test on the mobile Egoo Health system published in Natures Scientific Reports
Today, most people get their diagnosis through so-called quantitative polymerase chain reaction (qRT-PCR) which is performed in specialized laboratories. This means that it often takes more than 24…
not regulatory
2021-10-26 13:53
Nomination Committee appointed for Qlife Holding's Annual General Meeting 2022
In accordance with the decision at Qlife Holding's Annual General Meeting 2021, the company's Chairman of the Board has convened a Nomination Committee to prepare proposals for the Company's Annual…
not regulatory
2021-10-14 15:20
Qlife to participate in investor presentations in December 2021
Wednesday, December 1 at Stora Aktiedagen in Stockholm Time: 12.00-12.30 Thursday 2 December at Västra Hamnen in Malmö Time: TBD Investors, analysts and the media need to sign up for each event.…
regulatory
2021-09-21 16:30
Niklas Marschall leaves the Board of Qlife Holding AB
“It has been a fantastic journey that I am proud to have been a part of. My expertise is primarily to assist companies in the start-up phase, and that is really not Qlife anymore, and therefore it is…
regulatory
2021-08-16 08:30
QLIFE HOLDING AB INTERIM REPORT Q2, 2021
FINANCIAL SUMMARY – SECOND QUARTER 2021 Revenue in the period amounted to kSEK 10,482 (6,181). Sales regards COVID-19 tests from the test service center as well as Egoo.Health devices and capsules…
not regulatory
2021-07-15 12:16
Qlife has submitted a scientific study of the company's COVID-19 test for peer-review to be published in an international journal
Today, most people get their diagnosis through so-called quantitative polymerase chain reaction (qRT-PCR) which is performed in specialized laboratories. This means that it often takes more than 24…
not regulatory
2021-06-10 08:00
Qlife expands test capacity for Covid-19 during the European Football Championship in Copenhagen
In connection with the European Football Championship in Copenhagen in the coming weeks, Qlife is expanding its testing capacity for Covid-19 to give more people access to RT-PCR tests with…
not regulatory
2021-06-09 12:30
The ownership of Qlife's founders is divided into four owner companies
The division means that Thomas Warthoe’s, Peter Warthoe’s and Lars Bangsgaard's respective companies have acquired 1,201,200 shares each from PKV Consult IVS, and Ebbe Finding is now the sole owner…
regulatory
2021-06-02 08:00
Warrants of series TO 1 were subscribed to approximately 97.4 percent and Qlife Holding receives approximately SEK 38.1 million
The exercise period for the warrants of series TO 1 took place from May 3, 2021 up to and including May 31, 2021. The subscription price per share for the exercise of warrants of series TO 1 amounted…
regulatory
2021-05-20 08:00
Board members of Qlife subscribe for warrants
At the Annual General Meeting on May 5, 2021, an incentive program aimed at three new board members of the company was resolved.  The warrant terms are based on a market valuation according to…
not regulatory
2021-05-18 08:00
Qlife's Board of Directors and management exercise warrants of series TO1 for SEK 2.4 million
The warrant holders have the right to subscribe for one (1) new share in Qlife for each two (2) owned warrants of series TO1 at a price of SEK 17.50 per share. The number of warrants of series TO1…
regulatory
2021-05-05 12:50
Bulletin from the annual general meeting in Qlife Holding AB 5 May 2021
Resolution on adoption of accounts and allocation of the company’s result The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income…
regulatory
2021-05-05 08:00
QLIFE HOLDING AB INTERIM REPORT 2021, Q1
FINANCIAL SUMMARY - FIRST QUARTER 2021 Revenue in the period amounted to kSEK 11,176 (385). Revenue regards sales of COVID-19 tests from the test service center as well as Egoo.Health devices and…
not regulatory
2021-05-03 08:00
Subscription of warrants in Qlife Holding AB series TO 1 commences today, May 3, 2021
The subscription period runs from 3 May 2021 until 31 May 2021. Two (2) warrants entitle to subscription of one (1) new share in the Company at a price of SEK 17.50 per share. If all warrants are…
regulatory
2021-04-29 19:02
Qlife Holding AB carries out a directed share issue of approximately SEK 90 million.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA (THE “UNITED STATES”), AUSTRALIA, CANADA, HONG KONG,…
not regulatory
2021-04-23 11:30
Invitation to Qlife Q1 2021 report presentation May 5, 2021
Qlife invites investors, financial analysts and the media to a presentation where Thowas Warthoe will comment on the report. The report will be released at 08:…
regulatory
2021-04-22 14:25
Qlife leaves development programme at Herlev Hospital
Qlife has been part of a development programme at the oncology department at Herlev Hospital since 2018, intended to validate home monitoring of kidney cancer patients. The project has been delayed…
regulatory
2021-04-21 13:07
QLIFE signs exclusive European distribution agreement with Aidian
The agreement covers a range of European countries, including Sweden, Norway, Finland, Germany, Netherlands, Belgium, Luxembourg, Austria, Switzerland, Poland, Czech Republic, Hungary, Slovakia,…
regulatory
2021-04-12 08:00
Qlife publishes Annual report 2020
The report can be downloaded from the website or ordered via the company; info@Egoo.health.This disclosure contains information that Qlife Holding AB is obliged to make public pursuant to the Swedish…
regulatory
2021-03-31 20:16
Correction: Notice of annual general meeting in Qlife Holding AB
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. The shareholders of Qlife Holding AB…
regulatory
2021-03-31 08:15
Notice of annual general meeting in Qlife Holding AB
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. In light of the ongoing Covid-19…
regulatory
2021-03-31 08:00
The Nomination Committee’s proposals for new board members in Qlife
Qlife’s Nomination Committee proposes that the Annual General Meeting elects Mette-Marie Harild, Ulrik Harrysson and Mikael Persson as new Board members. Mette-Marie Harild, born 1958, has a long…
regulatory
2021-02-18 10:00
QLIFE HOLDING AB YEAR END REPORT 2020, Q4
FINANCIAL SUMMARY - FOURTH QUARTER 2020 Revenue in the period amounted to kSEK 9,122 (0). Sales regards COVID-19 test capacity to customers mainly within sports, through the partner KMD. EBITDA…
not regulatory
2021-01-29 08:00
Qlife receives order from Statens Serum Institut for COVID-19 testing
“It is of great importance for Qlife to get a significant order from a highly professional customer directly after the CE-marking. It manifests the demand for tests of laboratory quality combined…
not regulatory
2021-01-25 08:00
Qlife granted its first patent for Egoo.Health device
The Danish Patent Office has granted Qlife patent number DK180348 B1 for its biomarker detection unit. The biomarker detection unit consist of an integrated optical microelectromechanical system (…
not regulatory
2021-01-07 08:00
Qlife CE-marks COVID-19 test
The current CE-mark applies to the professional use of the test platform Egoo.Health for sale on the European market. The next step is to place the COVID-19 test in strategic locations, where it can…
regulatory
2020-12-22 10:59
Qlife raises loans of SEK 15 million to strengthen working capital ahead of the upcoming market launch.
Qlife expects to CE mark its COVID-19 test for professional use in the Egoo.Health system within short. With the CE mark, Qlife's cost-effective, fast, and mobile PCR tests can be marketed and sold…
not regulatory
2020-11-30 08:00
Qlife to increase decentralized testing of professional football in Denmark with Divisionsforeningen - Egoo.Health-platform placed in three clubs
Since May 2020, Qlife has been handling all testing for COVID-19 for professional football in Denmark. The test capacity includes weekly testing of all players and staff in league clubs in order to…
not regulatory
2020-11-27 13:57
Qlife will not respond to preliminary rejection by the Danish Medicines Agency for COVID-19 test – focus on receiving CE-marking by year-end
On November 13, Qlife was informed that the Danish Medicines Agency (Lægemiddelstyrelsen) had rejected the application for temporay approval in Denmark “in the interest of health protection” for the…
not regulatory
2020-11-24 08:45
Qlife receives order for COVID-19 tests to European Women’s Handball Championship 2020
”We will do our utmost to protect the participating players against the coronavirus”, says Frank Smith, Covid-19 Officer, European Handball Federation Euro 2020 “It requires testing with high…
regulatory
2020-11-19 11:30
Bulletin from the extraordinary shareholders’ meeting in Qlife Holding AB
Resolution on (A) employee option program; and (B) directed issue of warrants and approval of transfer of warrants The meeting resolved in accordance with the proposal from the board of directors to…
regulatory
2020-11-18 11:44
QLIFE HOLDING AB INTERIM REPORT Q3, 2020
FINANCIAL SUMMARY - THIRD QUARTER 2020 Revenue in the period amounted to kSEK 5,062 (714). Sales regards COVID-19 test capacity to customers mainly within sports, through the partner KMD. EBITDA…
regulatory
2020-11-13 17:55
Qlife: application for temporary approval in Denmark "in the interest of health protection" receives preliminary rejection by the Danish Medicines Agency
In parallel to the ongoing process of preparing and putting together the dossier for the CE-mark, Qlife has submitted an application for placing the product on the market at this stage, as it offers…
not regulatory
2020-11-03 09:03
Nomination Committee appointed for Qlife Holding's Annual General Meeting 2021
The Nomination Committee consists of the following persons, who together represent approximately 39 percent of the company's shares and votes. Sören Skjärbäk, appointed by PKV Consult IVS, Sören…
regulatory
2020-11-02 08:30
Notice of extraordinary shareholders’ meeting in Qlife Holding AB
Information regarding the coronavirus As a precautionary measure to reduce the risk of spreading the coronavirus, the board of directors of Qlife Holding AB (”Qlife”) has decided to keep planned…
regulatory
2020-10-30 12:00
Qlife CE-mark for COVID-19 test delayed 2-3 months – application for temporary approval in Denmark due to public health interest submitted
Qlife was originally expecting CE-mark for the product in October, but the company is now expecting approval within the coming two to three months. In the mean time, Qlife has submitted an…
not regulatory
2020-08-21 13:55
Qlife to expand their COVID-19 testing to include all professional handball in Denmark
Due to the increasing of infectious rates over the past few weeks, it has been agreed that Qlife will be handling all testing for COVID-19 for professional handball in Denmark. Testing will start…
regulatory
2020-08-18 09:45
QLIFE HOLDING AB INTERIM REPORT Q2, 2020
FINANCIAL SUMMARY – SECOND QUARTER 2020 Revenue in the period amounted to kSEK 6,181 (0) and is mainly related to sales to KMD regarding the agreement with Danish Football League to test players…
not regulatory
2020-07-30 15:14
Qlife extends contract with Divisionsforeningen
In cooperation with KMD, Qlife has extended the contract with Divisionsforeningen. The extended contract is the continuation of COVID-19 testing of players and personnel in the two best football…
not regulatory
2020-07-17 15:52
Qlife continues to work with professional sports, now abroad and within cycling
Qlife's focus on professional sports is centered around COVID-19 testing, which the company offers in collaboration with IT partner KMD. COVID-19 testing contracts have been closed with various…
regulatory
2020-07-08 08:30
Qlife hires Jakob Broberg Lind as Sales Director Clinical
Jakob has extensive experience from international sales and business development within MedTech and healthcare and brings an excellent record of results and achievements in complex and competitive…
not regulatory
2020-07-06 14:55
News letter - commercial activities and communication
In April we closed a contract with the professional Danish football league for regular testing of all players and staff for COVID-19 and delivery of test results were initiated already in week 22.…
regulatory
2020-06-22 15:58
Henrik Ljung will take the role of Chief Financial Officer, CFO, in Qlife Holding AB.
"Henrik Ljung brings broad experience to Qlife from financial reporting, IR, business control, finance management and corporate governance, all with a focus on fast-growing companies in the early…
not regulatory
2020-06-19 19:53
Qlife tests badminton players for COVID-19, for this weekend's RSL Final 4 play
KMD and Qlife has entered an agreement with Badminton Denmark to COVID-19 test all players in the final game of the Danish badminton tournament for clubs, RSL Final 4. "The fact that we COVID-19…
not regulatory
2020-06-04 11:25
MOVING CLOSER TO THE MARKET - PROFESSIONAL SPORTS, CULTURE AND ENTERTAINMENT
Geelmuyden Kiese and KMD announced earlier today that they have entered a partnership to provide smart and efficient Covid-19 test solutions for the professional sports, culture, and entertainment…
not regulatory
2020-06-02 10:27
Qlife to develop SARS-CoV-2 total antibody test
The first phase of developing the antibody test will be outsourced to an existing partner and is expected to take approximately three months. Thereafter, the project will be transferred to in-house…
regulatory
2020-05-20 14:00
Bulletin from the Annual General Meeting in Qlife Holding AB on May 20th, 2020
Resolution on adoption of accounts and allocation of the company’s result The annual general meeting resolved to adopt the income statement and balance sheet as well as the consolidated income…
regulatory
2020-05-20 08:15
Qlife Holding AB, Interim Report January – March 2020
FINANCIAL SUMMARY FIRST QUARTER 2020 Revenue for the period amounted to kSEK 385 (0) and regards a collaboration project with a Danish hospital. EBITDA for the period amounted to kSEK -5,732 (-1,…
regulatory
2020-05-12 16:35
Qlife has entered a first strategically important sales agreement for their COVID-19 test
The parties have agreed a testing plan for all players, judges and club staff for Covid-19 in the professional leagues (3F SuperLiga and NordicBet Liga). The parties have developed a test protocol…
not regulatory
2020-04-22 10:55
Qlife enters agreement with Nordsjællands Hospital to start validation of COVID-19 test
Qlife announces that it has entered into a research agreement with Nordsjællands Hospital (NOH), to continue the validation of the Egoo Sars-CoV-2 virus test. The focus of the collaboration is to…
regulatory
2020-04-16 10:00
Notice of annual shareholders’ meeting in Qlife Holding AB
Information regarding the coronavirus As a precautionary measure to reduce the risk of spreading the coronavirus, the board of directors of Qlife Holding AB (”Qlife”) has decided to keep planned…
not regulatory
2020-04-03 15:50
Qlife updates on process for COVID-19 test
Due to increased requests for information on route to market for Qlife’s COVID-19 test the company is updating the following:  After having finalized the licensing agreement to COVID-19…
regulatory
2020-03-31 16:55
Qlife to expand the Egoo.Health platform with COVID-19 test through licence deal
Qlife announces that it has closed a license and supply agreement with Aidian Oy to access and incorporate their patented SIBA® Technology into the Egoo.Health platform.  The companies have…
not regulatory
2020-03-13 16:30
Corona virus, COVID-19, has limited impact on Qlife Holding AB
Qlife went public on March 2 with a clear strategy for the next year, that strategy is still being followed and we do not see any large obstacles to it due to the Corona virus outbreak. The interest…
not regulatory
2020-03-02 08:45
Qlife commences trading on Nasdaq First North Growth Market
Qlife Holding AB announces that the trading in the company’s shares (short name: QLIFE) will commence today on the Nasdaq First North Growth Market in Stockholm. Qlife Holding AB (“Qlife”) belongs to…
not regulatory
2020-02-28 12:16
Qlife has been approved for listing on the Nasdaq First North Growth Market with first day of trading on March 2[nd,] 2020
The short name for the Company’s shares on Nasdaq First North is QLIFE. The short name for the TO1 series warrants is QLIFE TO1. Qlife has appointed G&W Fondkommission as certified advisor (…
not regulatory
2020-01-29 12:30
Qlife announces CE-mark for professional use for its first biomarker capsule on the Egoo Home System.
The Egoo Home System is an integrated platform consisting of a small device, disposable capsules, each a test for a specific biomarker, and a digital infrastructure that can share data with patient…
not regulatory
2019-11-28 10:37
New presentation from Stora Aktiedagen Stockholm on 25 Nov
CEO Thomas Warthoe will present Qlife at Stora Aktiedagen (Shareholder’s Day) in Stockholm on 25 November. Would you like to read more about the programme and how to sign up, see attached…
not regulatory
2019-11-06 10:20
Presentation of Qlife on Stora Aktiedagen (Shareholder’s Day)
CEO Thomas Warthoe will present Qlife at Stora Aktiedagen (Shareholder’s Day) in Gothenburg on 4 November and in Stockholm on 25 November. Would you like to read more about the programme and how to…
not regulatory
2019-11-06 09:11
Top Danish politicians were excited when testing their own biomarkers with Egoo
The home diagnostic device from Danish start-up Qlife can make the lives of patients with chronic diseases easier. This is the way forward towards a more human centered public health sector, says one…
not regulatory
2019-10-31 14:18
Qlife is showcased by the Danish Minister of Health and the Minister for Industry
Qlife is showcased by the Danish Minister of Health and the Minister for Industry, Business and Financial Affairs for the launch of new public program for innovative purchasing of medical equipment…
not regulatory
2019-10-16 16:20
Newsletter
In the enclosed Newsletter you will find updated information about our operations and preparations for next steps.
not regulatory
2019-10-14 10:58
Soon, everybody can test their own blood at home
Biomarkers in our blood can show us a lot about our health, the development of a disease or how tough we have been to our body during a workout. Up until now, these bio markers could only be measured…
not regulatory
2019-10-14 10:53
Qlife speaks at the Healthcare IoT conference on 24 October – managing patient data a vital question for the future!
Every day, the Danish healthcare system produces a large amount of data. In the future, new data sources, such as data from patients, personal health tools and apps, will substantially…
not regulatory
2019-10-14 10:51
Qlife participates at Intrum Stockholm Open on 18 October 2019!
Six interesting companies in total will present their businesses. Watch the video of the presentation

Qlife

Qlife Holding AB
Redaregatan 48
SE-252 36 Helsingborg, Sweden
info@egoo.health

Links

  • About
  • Investors
  • Egoo.health

Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarker and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information that can contribute to better treatment and potential prevention of diseases is facilitated. On March 2, 2020, Qlife Holding completed a listing on the Nasdaq First North Growth Market, Stockholm. The company currently has about 40 employees.